Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study

OBJECTIVE: This study aimed to investigate the impact of adjuvant chemotherapy on overall survival (OS) for pulmonary sarcomatoid carcinoma (PSC) and non-small-cell lung cancer (NSCLC) cohorts and to identify its potential risk factors. METHODS: A retrospective analysis was performed by querying the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Long, Liu, Zixuan, Wang, Changhui, Xie, Shuanshuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452885/
https://www.ncbi.nlm.nih.gov/pubmed/36091171
http://dx.doi.org/10.3389/fonc.2022.940839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452885/
https://www.ncbi.nlm.nih.gov/pubmed/36091171
http://dx.doi.org/10.3389/fonc.2022.940839

Ejemplares similares